MPW Medical Properties Trust Inc

Completed Approximately $5.5 Billion of Asset Monetization Transactions, Including February’s $2.5 Billion Senior Secured Notes Offering That Addresses All Debt Maturities Through 2026

Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2024, as well as certain events occurring subsequent to quarter end.

• Net loss of ($0.69) and Normalized Funds from Operations (“NFFO”) of $0.18 for the 2024 fourth quarter and net loss of ($4.02) and NFFO of $0.80 for the full-year 2024, all on a per share basis. Fourth quarter 2024 net loss includes approximately $415 million ($0.69 per share) in impairments and fair market value adjustments related to Prospect Medical Group (“Prospect”) and PHP Holdings (“PHP”);
• Completed a well-oversubscribed private offering of more than $2.5 billion of senior secured notes due in 2032 at a blended coupon rate of 7.885%, the proceeds from which will repay all debt maturities until October 2026 and result in expected combined cash and line of credit availability of $1.4 billion;
• Simultaneous to the senior secured notes offering, the Company amended its line of credit to share collateral with the new senior secured notes and received universal affirmation of the long-standing banking group’s approximate $1.5 billion commitment with a fully extended (at MPT’s option) maturity in June 2027;
• Commenced rent during the fourth quarter on a $50 million building improvement project in Idaho Falls, Idaho;
• Sold two post-acute properties and agreed to sell an additional general acute facility during January for combined proceeds of approximately $45 million; and
• Declared a regular quarterly dividend of $0.08 per share in February.

Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer, said, “We delivered on exactly what we said we would do in 2024 by using proceeds from transactions to accelerate repayment of debt maturities. Our global real estate portfolio remains attractive to sophisticated investors, as evidenced by our recent five-and-a-half times oversubscribed secured notes transaction. We improved the operator diversification of our portfolio and effectively addressed all debt maturities through 2026, positioning MPT to pursue a range of shareholder value initiatives in 2025.”

Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, operating results, and reconciliations of net (loss) income to NFFO, including per share amounts, all on a basis comparable to 2023 results.

PORTFOLIO UPDATE

Medical Properties Trust has total assets of approximately $14.3 billion, including $8.6 billion of general acute facilities, $2.4 billion of behavioral health facilities and $1.6 billion of post-acute facilities. As of December 31, 2024, MPT’s portfolio included 396 properties and approximately 39,000 licensed beds leased to or mortgaged by 53 hospital operating companies across the United States as well as in the United Kingdom, Switzerland, Germany, Spain, Finland, Colombia, Italy and Portugal.

Hospitals around Europe are benefiting from strong reimbursement trends, growing occupancy, and higher acuity levels. In the United Kingdom, private medical insurance utilization has reached an all-time high – enabling operators such as Circle Health to deliver strong financial performance driven by volume growth as increasingly complex cases are being addressed in the private sector.

In the United States, hospital fundamentals continue to broadly improve across the general acute segment as increasing admissions and growing surgical volumes are driving improved coverage. In the behavioral and post-acute segments, operators are reporting consistent growth in inpatient admissions as well as improvements in contract labor costs.

Following the first full quarter of operations since transitioning 15 hospitals to new operators in September, MPT is encouraged by performance trends being reported across this portfolio as well as by a fifth tenant who leased two additional facilities in November. Across this footprint, our tenants have reported improving volumes, increasing patient satisfaction, and stabilization of staffing and supplies.

In January, Prospect Medical Group commenced an in-court restructuring process under Chapter 11 of the U.S. Bankruptcy Code. In February, MPT entered into a Term Sheet providing for a settlement that will enable Prospect to sell its hospitals and the related real estate with MPT’s cooperation. This settlement is subject to Bankruptcy Court approval.

OPERATING RESULTS

Net loss for the fourth quarter and year ended December 31, 2024 was ($413 million) (($0.69) per share) and ($2.4 billion) (($4.02) per share), respectively, compared to net loss of ($664 million) (($1.11) per share) and net loss of ($556 million) (($0.93) per share) in the year earlier periods. Net loss for the quarter ended December 31, 2024 included, among other non-recurring items, approximately $415 million of impairments and fair market value adjustments related to Prospect and PHP.

NFFO for the fourth quarter and year ended December 31, 2024 was $108 million ($0.18 per share) and $483 million ($0.80 per share), respectively, compared to $218 million ($0.36 per share) and $951 million ($1.59 per share) in the year earlier periods.

CONFERENCE CALL AND WEBCAST

The Company has scheduled a conference call and webcast for February 27, 2025 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter and year ended December 31, 2024. The dial-in numbers for the conference call are 877-883-0383 (U.S.) and 412-902-6506 (International) along with passcode 9974897. The conference call will also be available via webcast in the Investor Relations section of the Company’s website, www.medicalpropertiestrust.com.

A telephone and webcast replay of the call will be available beginning shortly after the call’s completion. The telephone replay will be available through March 13, 2025, using dial-in numbers 877-344-7529 (U.S.), 855-669-9658 (Canada) and 412-317-0088 (International) along with passcode 1210933. The webcast replay will be available for one year following the call’s completion on the Investor Relations section of the Company’s website.

The Company’s supplemental information package for the current period will also be available on the Company’s website in the Investor Relations section.

The Company uses, and intends to continue to use, the Investor Relations page of its website, which can be found at www.medicalpropertiestrust.com, as a means of disclosing material nonpublic information and of complying with its disclosure obligations under Regulation FD, including, without limitation, through the posting of investor presentations that may include material nonpublic information. Accordingly, investors should monitor the Investor Relations page, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospital real estate with 396 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of December 31, 2024. MPT’s financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “estimate”, “target”, “anticipate”, “believe”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding our strategies, objectives, asset sales and other liquidity transactions (including the use of proceeds thereof), expected re-tenanting of facilities and any related regulatory approvals, and expected outcomes from Prospect’s Chapter 11 restructuring process. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the risk that the outcome and terms of the bankruptcy restructuring of Prospect will not be consistent with those anticipated by the Company; (ii) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (iii) the risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all; (iv) the risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all; (v) MPT’s ability to obtain or modify the terms of debt financing on attractive terms or at all, as a result of changes in interest rates and other factors, which may adversely impact its ability to pay down, refinance, restructure or extend its indebtedness as it becomes due, or pursue acquisition and development opportunities; (vi) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us; (vii) the ability of our tenants and operators to operate profitably and generate positive cash flow, remain solvent, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (viii) the risk that we are unable to monetize our investments in certain tenants at full value within a reasonable time period or at all; and (ix) the risks and uncertainties of litigation or other regulatory proceedings.

The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned “Risk Factors” in our Annual Report on Form 10-Ks and our Form 10-Qs, and as may be updated in our other filings with the SEC. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES   Consolidated Balance Sheets (Amounts in thousands, except for per share data) December 31, 2024 December 31, 2023 Assets (Unaudited) (A) Real estate assets Land, buildings and improvements, intangible lease assets, and other

$

11,259,842

 

$

13,237,187

 

Investment in financing leases

 

1,057,770

 

 

1,231,630

 

Real estate held for sale

 

34,019

 

 

-

 

Mortgage loans

 

119,912

 

 

309,315

 

Gross investment in real estate assets

 

12,471,543

 

 

14,778,132

 

Accumulated depreciation and amortization

 

(1,422,948

)

 

(1,407,971

)

Net investment in real estate assets

 

11,048,595

 

 

13,370,161

 

  Cash and cash equivalents

 

332,335

 

 

250,016

 

Interest and rent receivables

 

36,327

 

 

45,059

 

Straight-line rent receivables

 

700,783

 

 

635,987

 

Investments in unconsolidated real estate joint ventures

 

1,156,397

 

 

1,474,455

 

Investments in unconsolidated operating entities

 

439,578

 

 

1,778,640

 

Other loans

 

109,175

 

 

292,615

 

Other assets

 

471,404

 

 

457,911

 

Total Assets

$

14,294,594

 

$

18,304,844

 

  Liabilities and Equity Liabilities Debt, net

$

8,848,112

 

$

10,064,236

 

Accounts payable and accrued expenses

 

454,209

 

 

412,178

 

Deferred revenue

 

29,445

 

 

37,962

 

Obligations to tenants and other lease liabilities

 

129,045

 

 

156,603

 

Total Liabilities

 

9,460,811

 

 

10,670,979

 

  Equity Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding

 

-

 

 

-

 

Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 600,403 shares at December 31, 2024 and 598,991

 

 

 

 

shares at December 31, 2023

 

600

 

599

Additional paid-in capital

 

8,584,917

 

 

8,560,309

 

Retained deficit

 

(3,658,516

)

 

(971,809

)

Accumulated other comprehensive (loss) income

 

(94,272

)

 

42,501

 

Total Medical Properties Trust, Inc. Stockholders' Equity

 

4,832,729

 

 

7,631,600

 

  Non-controlling interests

 

1,054

 

 

2,265

 

Total Equity

 

4,833,783

 

 

7,633,865

 

Total Liabilities and Equity

$

14,294,594

 

$

18,304,844

 

  (A) Financials have been derived from the prior year audited financial statements. MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES   Consolidated Statements of Income (Unaudited)   (Amounts in thousands, except for per share data) For the Three Months Ended For the Twelve Months Ended December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023   Revenues Rent billed

$

166,965

 

$

78,421

 

$

719,749

 

$

803,375

 

Straight-line rent

 

43,695

 

 

(166,769

)

 

163,414

 

 

(127,894

)

Income from financing leases

 

9,819

 

 

19,412

 

 

63,651

 

 

127,141

 

Interest and other income

 

11,365

 

 

(53,447

)

 

48,733

 

 

69,177

 

Total revenues

 

231,844

 

 

(122,383

)

 

995,547

 

 

871,799

 

  Expenses Interest

 

101,466

 

 

102,338

 

 

417,824

 

 

411,171

 

Real estate depreciation and amortization

 

64,956

 

 

77,295

 

 

447,657

 

 

603,360

 

Property-related (A)

 

9,780

 

 

3,298

 

 

27,255

 

 

41,567

 

General and administrative

 

28,489

 

 

30,150

 

 

133,789

 

 

145,588

 

Total expenses

 

204,691

 

 

213,081

 

 

1,026,525

 

 

1,201,686

 

  Other (expense) income Gain (loss) on sale of real estate

 

3,497

 

 

(2,024

)

 

478,693

 

 

(1,815

)

Real estate and other impairment charges, net

 

(386,973

)

 

(283,619

)

 

(1,825,402

)

 

(376,907

)

Earnings (loss) from equity interests

 

2,923

 

 

(20,873

)

 

(366,642

)

 

13,967

 

Debt refinancing and unutilized financing (costs) benefit

 

(615

)

 

239

 

 

(4,292

)

 

285

 

Other (including fair value adjustments on securities)

 

(48,744

)

 

(17,861

)

 

(615,565

)

 

7,586

 

Total other expense

 

(429,912

)

 

(324,138

)

 

(2,333,208

)

 

(356,884

)

  Loss before income tax

 

(402,759

)

 

(659,602

)

 

(2,364,186

)

 

(686,771

)

  Income tax (expense) benefit

 

(9,563

)

 

(3,982

)

 

(44,101

)

 

130,679

 

  Net loss

 

(412,322

)

 

(663,584

)

 

(2,408,287

)

 

(556,092

)

Net income attributable to non-controlling interests

 

(526

)

 

(359

)

 

(1,984

)

 

(384

)

Net loss attributable to MPT common stockholders

$

(412,848

)

$

(663,943

)

$

(2,410,271

)

$

(556,476

)

  Earnings per common share - basic and diluted: Net loss attributable to MPT common stockholders

$

(0.69

)

$

(1.11

)

$

(4.02

)

$

(0.93

)

  Weighted average shares outstanding - basic

 

600,402

 

 

598,984

 

 

600,248

 

 

598,518

 

Weighted average shares outstanding - diluted

 

600,402

 

 

598,984

 

 

600,248

 

 

598,518

 

  Dividends declared per common share

$

0.08

 

$

0.15

 

$

0.46

 

$

0.88

 

  (A) Includes $3.9 million and $0.7 million of ground lease and other expenses (such as property taxes and insurance) paid directly by us and reimbursed by our tenants for the three months ended December 31, 2024 and 2023, respectively, and $13.7 million and $29.3 million for the twelve months ended December 31, 2024 and 2023, respectively. MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES         Reconciliation of Net (Loss) Income to Funds From Operations (Unaudited)         (Amounts in thousands, except for per share data) For the Three Months Ended   For the Twelve Months Ended December 31, 2024   December 31, 2023   December 31, 2024   December 31, 2023         FFO information:       Net loss attributable to MPT common stockholders

$

(412,848

)

 

$

(663,943

)

 

$

(2,410,271

)

 

$

(556,476

)

Participating securities' share in earnings

 

(139

)

 

 

(349

)

 

 

(946

)

 

 

(1,644

)

Net loss, less participating securities' share in earnings

$

(412,987

)

 

$

(664,292

)

 

$

(2,411,217

)

 

$

(558,120

)

        Depreciation and amortization

 

79,396

 

 

 

95,648

 

 

 

509,524

 

 

 

676,132

 

(Gain) loss on sale of real estate

 

(3,497

)

 

 

2,024

 

 

 

(478,693

)

 

 

1,815

 

Real estate impairment charges

 

300,987

 

 

 

112,112

 

 

 

980,263

 

 

 

167,966

 

Funds from operations

$

(36,101

)

 

$

(454,508

)

 

$

(1,400,123

)

 

$

287,793

 

        Write-off of billed and unbilled rent and other

 

(332

)

 

 

499,335

 

 

 

2,514

 

 

 

649,911

 

Other impairment charges, net

 

85,986

 

 

 

171,507

 

 

 

1,255,929

 

 

 

208,941

 

Litigation and other

 

4,801

 

 

 

2,899

 

 

 

51,308

 

 

 

15,886

 

Share-based compensation adjustments

 

-

 

 

 

(6,571

)

 

 

-

 

 

 

(9,691

)

Non-cash fair value adjustments

 

52,194

 

 

 

8,405

 

 

 

563,666

 

 

 

(34,157

)

Tax rate changes and other

 

523

 

 

 

(2,797

)

 

 

5,119

 

 

 

(167,332

)

Debt refinancing and unutilized financing costs (benefit)

 

615

 

 

 

(239

)

 

 

4,292

 

 

 

(285

)

Normalized funds from operations

$

107,686

 

 

$

218,031

 

 

$

482,705

 

 

$

951,066

 

        Certain non-cash and related recovery information:       Share-based compensation

$

2,321

 

 

$

10,102

 

 

$

32,902

 

 

$

42,941

 

Debt costs amortization

$

5,292

 

 

$

4,933

 

 

$

20,061

 

 

$

20,273

 

Non-cash rent and interest revenue (A)

$

-

 

 

$

(57,920

)

 

$

-

 

 

$

(239,599

)

Cash recoveries of non-cash rent and interest revenue (B)

$

542

 

 

$

2,364

 

 

$

7,382

 

 

$

38,451

 

Straight-line rent revenue from operating and finance leases

$

(48,627

)

 

$

(63,282

)

 

$

(178,022

)

 

$

(247,699

)

                Per diluted share data:       Net loss, less participating securities' share in earnings

$

(0.69

)

 

$

(1.11

)

 

$

(4.02

)

 

$

(0.93

)

Depreciation and amortization

 

0.14

 

 

 

0.16

 

 

 

0.86

 

 

 

1.13

 

(Gain) loss on sale of real estate

 

(0.01

)

 

 

-

 

 

 

(0.80

)

 

 

-

 

Real estate impairment charges

 

0.50

 

 

 

0.19

 

 

 

1.63

 

 

 

0.28

 

Funds from operations

$

(0.06

)

 

$

(0.76

)

 

$

(2.33

)

 

$

0.48

 

        Write-off of billed and unbilled rent and other

 

-

 

 

 

0.83

 

 

 

-

 

 

 

1.09

 

Other impairment charges, net

 

0.14

 

 

 

0.29

 

 

 

2.08

 

 

 

0.35

 

Litigation and other

 

0.01

 

 

 

-

 

 

 

0.09

 

 

 

0.03

 

Share-based compensation adjustments

 

-

 

 

 

(0.01

)

 

 

-

 

 

 

(0.02

)

Non-cash fair value adjustments

 

0.09

 

 

 

0.01

 

 

 

0.94

 

 

 

(0.06

)

Tax rate changes and other

 

-

 

 

 

-

 

 

 

0.01

 

 

 

(0.28

)

Debt refinancing and unutilized financing costs (benefit)

 

-

 

 

 

-

 

 

 

0.01

 

 

 

-

 

Normalized funds from operations

$

0.18

 

 

$

0.36

 

 

$

0.80

 

 

$

1.59

 

        Certain non-cash and related recovery information:       Share-based compensation

$

-

 

 

$

0.02

 

 

$

0.05

 

 

$

0.07

 

Debt costs amortization

$

0.01

 

 

$

0.01

 

 

$

0.03

 

 

$

0.03

 

Non-cash rent and interest revenue (A)

$

-

 

 

$

(0.10

)

 

$

-

 

 

$

(0.40

)

Cash recoveries of non-cash rent and interest revenue (B)

$

-

 

 

$

-

 

 

$

0.01

 

 

$

0.06

 

Straight-line rent revenue from operating and finance leases

$

(0.08

)

 

$

(0.11

)

 

$

(0.30

)

 

$

(0.41

)

Notes:

Investors and analysts following the real estate industry utilize funds from operations ("FFO") as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or Nareit, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization, including amortization related to in-place lease intangibles, and after adjustments for unconsolidated partnerships and joint ventures.

In addition to presenting FFO in accordance with the Nareit definition, we disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs (if any not paid by our tenants) to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our results of operations or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

Certain line items above (such as depreciation and amortization) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with all activity of our equity interests in the "Earnings (loss) from equity interests" line on the consolidated statements of income.

(A) Includes revenue accrued during the period but not received in cash, such as deferred rent, payment-in-kind ("PIK") interest or other accruals.

(B) Includes cash received to satisfy previously accrued non-cash revenue, such as the cash receipt of previously deferred rent or PIK interest.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250226322304/en/

Drew Babin, CFA, CMA Head of Financial Strategy and Investor Relations Medical Properties Trust, Inc. (646) 884-9809 dbabin@medicalpropertiestrust.com